- Min.Order :1 Kilogram
- Purity: 99%
- Payment Terms : T/T
Keywords
Upadacitinib hemihydrate 2050057-56-0 99%
Quick Details
- Appearance:color
- Application:INTERMEDITD
- PackAge:According to your
- ProductionCapacity:1|Kilogram|Day
- Storage:storage temp
- Transportation:Air，Sea，courier
Superiority:
Upadacitinib hemihydrate
1-Pyrrolidinecarboxamide,3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-,hydrate(2:1),(3S,4R)-;UpadacitinibhemihydraChemicalbookte;UpadacitinibHydrate;Cinchonanium,1-[13,5-bis(trifluoromethyllphenyllmethyl]-9-hydroxy-1'-[[3-(trifluoromethyl)phenyllmethyl},bromide(1:2),(8a,9R)-"
InChIKeyVJSRYIXHEWRBKD-NFGOAHBONA-NSMILESC([C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1C1=CN=C2C=NC3NC=CC=3N12)C.O |&1:1,13,r|
2050057-56-0
C17H21F3N6O2
398.39
Details:
Upadacitinib is an oral Janus kinase (JAK)1-selective inhibitor and a disease-modifying antirheumatic drug (DMARD)1. It is used in the treatment of rheumatoid arthritis to slow down disease progression1. Rheumatoid arthritis is a chronic autoimmune inflammatory disease affecting the peripheral joints1. Upadacitinib works by blocking the action of enzymes called Janus kinases, which are involved in setting up processes that lead to inflammation
Upadacitinib hemihydrate
1-Pyrrolidinecarboxamide,3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-,hydrate(2:1),(3S,4R)-;UpadacitinibhemihydraChemicalbookte;UpadacitinibHydrate;Cinchonanium,1-[13,5-bis(trifluoromethyllphenyllmethyl]-9-hydroxy-1'-[[3-(trifluoromethyl)phenyllmethyl},bromide(1:2),(8a,9R)-"
InChIKeyVJSRYIXHEWRBKD-NFGOAHBONA-NSMILESC([C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1C1=CN=C2C=NC3NC=CC=3N12)C.O |&1:1,13,r|
2050057-56-0
C17H21F3N6O2
398.39
You Might Also Like
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View